Free Trial

bioAffinity Technologies (BIAF) Competitors

bioAffinity Technologies logo
$0.33 +0.04 (+12.67%)
Closing price 04:00 PM Eastern
Extended Trading
$0.31 -0.02 (-5.15%)
As of 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

BIAF vs. RSLS, OFAL, XBP, GLE, SWAG, WAI, DTST, SCOR, FPAY, and SGRP

Should you be buying bioAffinity Technologies stock or one of its competitors? The main competitors of bioAffinity Technologies include ReShape Lifesciences (RSLS), OFA Group (OFAL), XBP Europe (XBP), Global Engine Group (GLE), Stran & Company, Inc. (SWAG), Top KingWin (WAI), Data Storage (DTST), comScore (SCOR), FlexShopper (FPAY), and SPAR Group (SGRP).

bioAffinity Technologies vs. Its Competitors

ReShape Lifesciences (NASDAQ:RSLS) and bioAffinity Technologies (NASDAQ:BIAF) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, profitability, risk, earnings, institutional ownership, media sentiment, analyst recommendations and dividends.

bioAffinity Technologies has a consensus price target of $6.00, indicating a potential upside of 1,718.18%. Given bioAffinity Technologies' higher possible upside, analysts plainly believe bioAffinity Technologies is more favorable than ReShape Lifesciences.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
ReShape Lifesciences
0 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00
bioAffinity Technologies
0 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00

ReShape Lifesciences has a net margin of -48.26% compared to bioAffinity Technologies' net margin of -110.53%. ReShape Lifesciences' return on equity of -251.90% beat bioAffinity Technologies' return on equity.

Company Net Margins Return on Equity Return on Assets
ReShape Lifesciences-48.26% -251.90% -59.49%
bioAffinity Technologies -110.53%-367.64%-154.15%

In the previous week, bioAffinity Technologies had 1 more articles in the media than ReShape Lifesciences. MarketBeat recorded 2 mentions for bioAffinity Technologies and 1 mentions for ReShape Lifesciences. ReShape Lifesciences' average media sentiment score of 1.87 beat bioAffinity Technologies' score of 0.14 indicating that ReShape Lifesciences is being referred to more favorably in the media.

Company Overall Sentiment
ReShape Lifesciences Very Positive
bioAffinity Technologies Neutral

ReShape Lifesciences has higher earnings, but lower revenue than bioAffinity Technologies. bioAffinity Technologies is trading at a lower price-to-earnings ratio than ReShape Lifesciences, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
ReShape Lifesciences$8.01M0.84-$7.13M-$193.23-0.01
bioAffinity Technologies$9.36M1.00-$9.04M-$0.72-0.46

ReShape Lifesciences has a beta of 1.16, indicating that its share price is 16% more volatile than the S&P 500. Comparatively, bioAffinity Technologies has a beta of 2.52, indicating that its share price is 152% more volatile than the S&P 500.

22.1% of ReShape Lifesciences shares are owned by institutional investors. Comparatively, 1.6% of bioAffinity Technologies shares are owned by institutional investors. 0.0% of ReShape Lifesciences shares are owned by insiders. Comparatively, 16.9% of bioAffinity Technologies shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Summary

ReShape Lifesciences and bioAffinity Technologies tied by winning 7 of the 14 factors compared between the two stocks.

Get bioAffinity Technologies News Delivered to You Automatically

Sign up to receive the latest news and ratings for BIAF and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding BIAF and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

BIAF vs. The Competition

MetricbioAffinity TechnologiesMED IndustryMedical SectorNASDAQ Exchange
Market Cap$8.34M$2.91B$5.52B$9.32B
Dividend YieldN/A2.46%4.25%4.05%
P/E Ratio-0.4620.3628.1519.68
Price / Sales1.00302.56437.63100.28
Price / CashN/A42.3835.5357.53
Price / Book1.947.768.235.67
Net Income-$9.04M-$55.11M$3.23B$257.51M
7 Day Performance-2.94%0.95%-0.01%0.52%
1 Month Performance25.86%8.44%5.61%8.84%
1 Year Performance-86.42%-2.38%26.52%14.18%

bioAffinity Technologies Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
BIAF
bioAffinity Technologies
1.3675 of 5 stars
$0.33
+12.7%
$6.00
+1,718.2%
-88.4%$8.34M$9.36M-0.4610News Coverage
Gap Up
RSLS
ReShape Lifesciences
0.6099 of 5 stars
$2.38
+0.4%
N/A-99.2%$5.65M$8.01M-0.0150
OFAL
OFA Group
N/A$1.97
-4.4%
N/AN/A$27.52M$386.36K0.006News Coverage
Gap Up
XBP
XBP Europe
N/A$0.89
-1.2%
N/A-39.8%$27.36M$142.77M0.001,450Gap Down
GLE
Global Engine Group
N/A$1.49
-1.3%
N/AN/A$27.18M$6.33M0.003
SWAG
Stran & Company, Inc.
2.4375 of 5 stars
$1.40
-2.1%
N/A+30.5%$26.61M$92.52M-6.3670Gap Down
WAI
Top KingWin
N/A$0.72
-80.2%
N/AN/A$26.57M$3.75M0.00N/AGap Down
High Trading Volume
DTST
Data Storage
0.8433 of 5 stars
$3.53
-1.4%
N/A-47.1%$25.56M$25.37M176.5960News Coverage
Positive News
Analyst Forecast
Gap Up
SCOR
comScore
2.5812 of 5 stars
$5.06
+0.8%
$10.75
+112.5%
-61.0%$24.84M$356.05M-0.321,200Gap Down
FPAY
FlexShopper
3.5753 of 5 stars
$0.99
-13.9%
$3.25
+228.3%
-13.5%$24.68M$139.80M-4.30140
SGRP
SPAR Group
3.6486 of 5 stars
$0.91
-3.0%
N/A-56.3%$22.06M$196.81M1.793,425

Related Companies and Tools


This page (NASDAQ:BIAF) was last updated on 7/16/2025 by MarketBeat.com Staff
From Our Partners